A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis

2019243 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Hepatology

Volume 72, Issue 5, pp. 816-827

Field-Weighted Citation Impact: 22.06